Glaucoma News and Research

Latest Glaucoma News and Research

Professor of neurology outlines case studies of hallucinations of musical notation

Professor of neurology, physician, and author Oliver Sacks M.D. has outlined case studies of hallucinations of musical notation, and commented on the neural basis of such hallucinations, in a new paper for the neurology journal Brain.

5 Apr 2013

Lund University researchers examine why people suffer vision loss in eye diseases

Using new technology and new approaches, researchers at Lund University in Sweden hope to be able to explain why people suffer vision loss in eye diseases such as retinal detachment and glaucoma.

4 Apr 2013

pSivida announces resubmission of ILUVIEN NDA to FDA for chronic diabetic macular edema

pSivida Corp., a specialty pharmaceutical company that is a leader in the development of sustained release ophthalmic drug treatments, today announced that its licensee Alimera Sciences, Inc. reported the submission of its response to the second Complete Response Letter from the U.S. Food and Drug Administration with respect to ILUVIEN for chronic diabetic macular edema.

2 Apr 2013

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

VIVUS, Inc. announced today that a new study demonstrates that effective medical treatment providing 10% to 15% weight loss could lead to significant improvements in Medicare spending by reversing or reducing significant health consequences such as type 2 diabetes, hypertension and dyslipidemia in obese or overweight patients.

25 Mar 2013

R-Tech Ueno enrolls retinitis pigmentosa patients in Phase 3 clinical study of UF-021 ophthalmic solution

R-Tech Ueno is pleased to announce the start of the patient enrollment of a Phase 3 clinical study with Unoprostone (development code UF-021) ophthalmic solution that are being developed in our company for the treatment of retinitis pigmentosa.

18 Mar 2013

Reduced visual sensitivity seen with use of multifocal intraocular lenses

Recent study findings indicate that eyes with multifocal intraocular lenses implanted during cataract surgery may develop reduced visual sensitivity.

8 Mar 2013

Oraya Therapy safe and effective for patients with wet AMD

Oraya Therapeutics, Inc. today announced that one of the patients who successfully was treated for wet age-related macular degeneration (AMD) with Oraya Therapy during the INTREPID clinical trial has released data showing he has experienced significant, sustained vision improvement more than two years after treatment in his right eye, without any subsequent anti-vascular endothelial growth factor (anti-VEGF) injections or other treatment.

1 Mar 2013

Vision CRC develops retinal camera for detection of blinding eye disease and general health disorders

The most advanced technology for use in real-time detection and assessment of common blinding eye disease and general health disorders will soon be available to the world with stimulus funding provided for development by the Australian Government's CRC Program.

27 Feb 2013

Sucampo launches RESCULA Eye Drops in the U.S.

Sucampo Pharmaceuticals, Inc. announced that RESCULA Eye Drops had been launched in the U.S. market.

21 Feb 2013

Sucampo's RESCULA 0.15% now available by prescription across the U.S.

Sucampo Pharmaceuticals, Inc. today announced that RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% is now available by prescription across the United States. The U.S. Food and Drug Administration (FDA) approved a sNDA for RESCULA for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension on December 7, 2012.

19 Feb 2013

Meridian Health, Bayshore Community Hospital announce $5 million charitable contribution

Bayshore Community Hospital and Meridian Health Affiliated Foundations today announced a $5 million charitable contribution from Mrs. Janice Mitchell Vassar, whose sole desire, in her words, is to "make my hospital the best hospital it can be."

16 Feb 2013

Pediatric blindness etiology varies around the globe

The causes and prevalence of blindness in children vary markedly by geography, presumably as a proxy for socioeconomic factors influencing prevention and treatment schemes, conclude the authors of a literature review.

15 Feb 2013

Santarus launches UCERIS for induction of remission in patients with ulcerative colitis

Santarus, Inc. announced today the U.S. commercial launch of UCERIS (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis.

14 Feb 2013

$Scientists discover 24 new genes that cause refractive errors and myopia$

Scientists discover 24 new genes that cause refractive errors and myopia

An international team of scientists led by King's College London has discovered 24 new genes that cause refractive errors and myopia (short-sightedness).

10 Feb 2013

Intravitreal ranibizumab shows little benefit after hemorrhage

Ranibizumab given intravitreally offers no clear benefit in the treatment of vitreous hemorrhage due to proliferative diabetic retinopathy, a randomized clinical trial indicates.

8 Feb 2013

Selective laser trabeculoplasty promising for glaucoma

Selective laser trabeculoplasty leads to significant reductions in intraocular pressure in people with primary open-angle glaucoma, a study has found.

6 Feb 2013

New survey outlines funding deficiency in brain and eye disease research

BrightFocus Foundation, a nonprofit organization that funds research worldwide to save sight and mind, today released the results of a survey of more than 170 leading biomedical scientists that explores the most significant barriers to progress in ending brain and eye diseases.

2 Feb 2013

National Eye Institute’s booklet and videos help people adapt to life with low vision

A 20-page large-print booklet and a series of videos to help people adapt to life with low vision are available from the National Eye Institute (NEI), a part of the National Institutes of Health. The materials were released during Low Vision Awareness Month, February 2013.

2 Feb 2013

ADRB receptors play a direct role in Src activation by PKA-mediated mechanism

Scientists at The University of Texas MD Anderson Cancer Center have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones. The researchers report in the current issue of Nature Communications that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.

30 Jan 2013

Study explores regular aspirin use and potential risks for macular degeneration

This week, a study published in the journal JAMA Internal Medicine, explored the connection between regular aspirin use and the potential risks for developing the blinding eye disease, macular degeneration. As a result, there is increased confusion and anxiety in the general public about whether aspirin can harm your vision and what to do if you need the heart-protective therapy.

28 Jan 2013

Glaucoma News and Research

Latest Glaucoma News and Research

Professor of neurology outlines case studies of hallucinations of musical notation

Lund University researchers examine why people suffer vision loss in eye diseases

pSivida announces resubmission of ILUVIEN NDA to FDA for chronic diabetic macular edema

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

R-Tech Ueno enrolls retinitis pigmentosa patients in Phase 3 clinical study of UF-021 ophthalmic solution

Reduced visual sensitivity seen with use of multifocal intraocular lenses

Oraya Therapy safe and effective for patients with wet AMD

Vision CRC develops retinal camera for detection of blinding eye disease and general health disorders

Sucampo launches RESCULA Eye Drops in the U.S.

Sucampo's RESCULA 0.15% now available by prescription across the U.S.

Meridian Health, Bayshore Community Hospital announce $5 million charitable contribution

Pediatric blindness etiology varies around the globe

Santarus launches UCERIS for induction of remission in patients with ulcerative colitis

Scientists discover 24 new genes that cause refractive errors and myopia

Intravitreal ranibizumab shows little benefit after hemorrhage

Selective laser trabeculoplasty promising for glaucoma

New survey outlines funding deficiency in brain and eye disease research

National Eye Institute’s booklet and videos help people adapt to life with low vision

ADRB receptors play a direct role in Src activation by PKA-mediated mechanism

Study explores regular aspirin use and potential risks for macular degeneration

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Glaucoma News and Research

Latest Glaucoma News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in